Showing recent highlights
What's New
PubMed · September 5, 2026
Researchers found that ellagic acid — a natural compound found in foods like pomegranates, berries, and walnuts — may help protect bones by encouraging the growth of bone-building cells while slowing down the cells that break bone down, which is exactly the imbalance that causes osteoporosis (a condition where bones become weak and fragile). These findings come from lab and animal studies, so scientists don't yet know if the same effects would happen in people. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · September 4, 2026
Researchers found that when people with osteoporosis stop taking a bone-strengthening medication called denosumab, their bones can lose density quickly and their risk of spinal fractures rises sharply — a kind of 'rebound' effect. The study looked at whether taking a different bone medication afterward (specifically drugs like alendronate or zoledronic acid, which work by slowing bone breakdown) could help protect against those fractures, and found that it was linked to a major reduction in spinal fractures compared to taking nothing or a different type of medication. This matters because many people do eventually stop denosumab, and knowing what might come next is an important part of long-term bone care conversations with their doctor. This is early research and hasn't yet changed treatment guidelines.
What's New
ScienceDaily · September 2, 2026
A study following nearly 10,000 older women over 10 years found that drinking tea was linked to slightly stronger hip bones, while drinking more than five cups of coffee a day was linked to weaker bones — though moderate coffee drinking did not appear to be a problem. This matters for people with osteoporosis, a condition where bones become thinner and more fragile over time, because even small changes in bone strength can affect their risk of fractures. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · September 1, 2026
Researchers found that people with chronic pain conditions — including fibromyalgia, rheumatoid arthritis, and knee or hip osteoarthritis — reported improvements in pain, mental health, and physical functioning after taking capsules containing different combinations of cannabis compounds over 12 weeks. All three formulas tested showed benefits, though none stood out as clearly superior to the others. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · September 1, 2026
A study found that people with osteoporosis caused by long-term steroid use who switched to a bone-building medication called romosozumab (brand name Evenity) showed slightly greater improvements in bone density compared to those who stayed on their existing bone medications — even though the patients who switched were older and had weaker bones to begin with. Bone density, which measures how strong and solid bones are, improved at several points in the body over 12 months in the romosozumab group. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · September 1, 2026
Researchers found that roughly 1 in 10 adults studied across Latin America had experienced a fragility fracture — a break in the bone caused by osteoporosis, where bones become weak and brittle. Vertebral fractures, meaning breaks in the small bones of the spine, were the most common type found. This matters because fractures from osteoporosis can lead to serious pain, disability, and even death, and understanding how widespread the problem is in Latin America could help health systems better prepare to support affected patients. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · September 1, 2026
Researchers found that artificial intelligence (AI) tools trained to read chest X-rays — images already taken for other reasons like checking the lungs — could also detect signs of osteoporosis (a condition that weakens bones and raises the risk of fractures) with reasonable accuracy. This matters because many people with osteoporosis don't know they have it until a bone breaks, and using X-rays that patients are already getting could be a low-cost way to catch it earlier without extra tests. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · August 28, 2026
Researchers found that traditional Chinese medicine treatments — including herbal remedies and other practices — may help postmenopausal women with osteoporosis (a condition where bones become weaker and more likely to break) by improving bone density and reducing pain. The analysis looked at hundreds of studies and found meaningful improvements, though the quality and design of those studies varied quite a bit, making it hard to draw firm conclusions. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · August 18, 2026
Researchers found that a traditional Chinese herbal remedy called Weishen Decoction helped older adults with osteoporosis — a condition where bones become weak and fragile — feel better and showed some early signs of improving bone strength in the hip area, compared to a sugar pill (placebo). About two-thirds of people taking the herbal remedy reported meaningful improvement in back pain and related symptoms, versus about four in ten in the placebo group, and no serious side effects were reported in either group over the 12-week study. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · August 17, 2026
Researchers found that even when family doctors recognized a fracture as likely caused by weak bones — a warning sign for osteoporosis — many patients still didn't receive follow-up bone scans or treatment. In fact, fewer than half of those patients were started on any bone-strengthening treatment after their fracture. This matters because a fracture from a minor bump or fall can be a signal that bones are fragile, and missing that window for follow-up care may leave people at higher risk for another, potentially more serious break. This is early research and hasn't yet changed treatment guidelines.
Guidelines
PubMed (Guideline Reviews) · August 11, 2026
According to the Chinese Health Risk Management Collaboration-Osteoporosis Group guidelines, people at risk for osteoporosis — a condition where bones become weak and more likely to break — should focus on everyday habits like eating enough calcium and protein, getting vitamin D (through food or sunlight), staying active, maintaining a healthy weight, and avoiding smoking and heavy alcohol use. These recommendations are designed to be practical for the general public, not just doctors, because awareness of bone health in China has been low even as the population ages. The guidelines also outline specific tools their doctor can use to check a person's risk of fractures before problems develop.
What's New
PubMed · August 10, 2026
Researchers found that for middle-aged and older adults with osteoporosis — a condition where bones become weaker and more likely to break — the sweet spot for resistance (weight-based) exercise appears to be moderate intensity three times per week, which was linked to meaningful improvements in bone density at the hip and spine. High-intensity resistance exercise done twice a week also showed strong results for overall body bone density. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · August 1, 2026
Researchers found that people who take glucocorticoids — a type of steroid medication commonly used to treat conditions like arthritis, asthma, or lupus — tend to have weaker bone quality compared to people who don't take these medications. The study used a measurement called the Trabecular Bone Score (TBS), which looks at the inner texture and strength of bone (not just its density), and found it was consistently lower in steroid users across different sexes, ethnicities, and body types — suggesting that standard bone density scans alone may miss some of the bone-weakening effects of these drugs. For someone with osteoporosis (a condition where bones become thin and fragile and break more easily), this matters because it hints that TBS testing alongside regular bone scans might give a fuller picture of fracture risk. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · August 1, 2026
Researchers found that a type of 3D dental or medical scan called a cone beam CT (CBCT) — a detailed imaging tool some people get at the dentist or for other reasons — can moderately detect low bone density, which is the main concern in osteoporosis (a condition where bones become weak and fragile). The scan was better at correctly identifying people who did NOT have low bone density than at catching everyone who did, meaning it occasionally missed cases. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · July 9, 2026
Researchers found that taking potassium citrate — a supplement that helps balance acid levels in the body — may help slow down bone loss in postmenopausal women, at least in the short term. Specifically, after one month, the supplement appeared to reduce a marker in the urine that signals bones are breaking down faster than they're being rebuilt — though this effect wasn't clearly seen at longer time points like 3, 6, or 12 months. For someone with osteoporosis (a condition where bones become weak and fragile), this is an interesting early signal worth watching, but this is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · July 7, 2026
Researchers found that certain minimally invasive spine procedures — where a doctor uses a needle to stabilize a broken vertebra (a bone in the spine weakened by osteoporosis) — may relieve pain and improve mobility better than others, with some newer techniques ranking highest for both short-term and longer-term pain relief. For people with osteoporosis, spinal fractures are a major cause of ongoing back pain and difficulty moving, so understanding which procedures work best could be meaningful for treatment decisions. This is early research and hasn't yet changed treatment guidelines.
What's New
JAMA · July 7, 2026
Researchers found that some medications already available to help prevent bone fractures in people with osteoporosis — a condition where bones become weak and brittle — may not be used as often as they could be, and that estrogen in particular is poorly understood by many doctors and patients. This matters because people with osteoporosis who are at risk of painful or disabling fractures might be missing out on treatment options that already exist. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · July 2, 2026
A study found that bisphosphonates — medications commonly used to strengthen bones in people with osteoporosis — may slow down or reduce the movement of teeth during orthodontic (braces) treatment. This matters because more adults are receiving orthodontic treatment while also taking these bone medications, and their dentist or orthodontist may need to be aware of this possible interaction. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · July 1, 2026
Researchers found that older adults who did high-intensity resistance training — lifting heavier weights that really challenge the muscles — gained significantly more leg strength compared to those who did lighter, easier workouts. However, both approaches seemed equally effective at maintaining bone density, which is the measure of how strong and solid bones are — something especially important for people with osteoporosis, where bones become thinner and more prone to breaking. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · July 1, 2026
Researchers found that postmenopausal women who took a daily calcium supplement — whether in a standard form (calcium carbonate) or a newer dairy-based form called calcium-enriched permeate — showed a meaningful reduction in a blood marker linked to bone breakdown, compared to those who took a placebo (a dummy pill with no active ingredient). This matters for people with osteoporosis because slowing bone breakdown is a key part of keeping bones stronger as we age. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · July 1, 2026
Researchers found that exercise — particularly moderate-intensity running and jumping movements — helped partially restore bone density in rats whose bones had weakened after their ovaries were removed, which is used as a stand-in model for what happens to women's bones after menopause when estrogen levels drop. The exercise also appeared to slow down bone loss by reducing markers of bone breakdown, meaning the body was destroying less bone tissue. This is early research and hasn't yet changed treatment guidelines.
Lifestyle
ScienceDaily · June 25, 2026
Unable to generate summary: 'medical press release' is not a recognized content type. Please resubmit with a supported content type.
What's New
ScienceDaily · June 15, 2026
A major review of nearly 154,000 people found that calcium supplements, vitamin D supplements, or taking both together did little to protect older adults from broken bones or falls. This challenges a long-held belief that these supplements are a reliable way to keep bones strong as people age, which could matter a great deal for people with osteoporosis — a condition where bones become weak and more likely to break. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · June 12, 2026
Researchers looked at a traditional Chinese herb called Rhizoma Drynariae — sometimes called drynaria — and found that extracts from it appeared to improve bone density and bone strength in rats with osteoporosis, which is a condition where bones become weak and brittle and break more easily. This is interesting because the herb seemed to affect several measures of bone health at once, which might eventually point scientists toward new ways to support bone health in people. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · June 2, 2026
Researchers found that an AI-powered chatbot designed to teach people with osteoporosis — a condition where bones become weak and fragile — how to manage their health performed comparably to traditional face-to-face education from nurses, while also freeing up significant nursing time. People who used the chatbot showed similar improvements in their knowledge about osteoporosis and were just as likely to stick to their care routines over the following months. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · June 1, 2026
Researchers found that a newer version of a bone-strengthening drug called Bmab 1000 worked about as well as the original drug (denosumab) at improving bone density — the measure of how strong and dense bones are — in women whose bones had become fragile after menopause, which is called osteoporosis. They also found that people who switched from the original drug to Bmab 1000 did not seem to have problems with safety, which could eventually matter because biosimilar drugs (essentially lower-cost copies of an original drug) might make treatment more accessible for people with osteoporosis. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · June 1, 2026
Researchers found that a biosimilar version of denosumab — a medication used to treat osteoporosis by slowing bone loss — worked just as well and was just as safe as the original brand-name version, based on data from nearly 1,800 patients. Both versions produced similar improvements in bone density (a measure of how strong and solid bones are) at the spine, hip, and femoral neck (the top of the thigh bone), and side effects were comparable between the two. This matters because biosimilars are often less expensive than the original medication, which could make treatment more accessible for people with osteoporosis. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · May 22, 2026
A review of studies found that older men with osteoporosis — a condition where bones become weak and fragile — are often not diagnosed or treated, even though their risk of breaking a bone is significant. Researchers found that certain bone medications, as well as resistance exercise (like weight training for 60–90 minutes a day), showed some promise in strengthening bones, though the evidence wasn't strong enough to confirm they reliably prevent fractures. Because research in this area is still limited, men with osteoporosis may want to ask their doctor what treatment and lifestyle options have been considered for them specifically.
Ask your doctor: Ask the doctor whether the patient should be screened for osteoporosis and what combination of medicines and lifestyle changes would work best to prevent fractures.
What's New
PubMed · May 20, 2026
A study looked at whether taking calcium, vitamin D, or both together could help prevent broken bones and falls in adults, pulling together results from 69 studies with over 153,000 people. Researchers found that for most adults who were generally healthy and not already at high risk of fractures, these supplements had little to no effect on preventing broken bones. People with osteoporosis — a condition that weakens bones and makes them more likely to break — may want to ask their doctor whether supplements are the right approach for their specific situation, since this research suggests they don't work the same way for everyone.
Ask your doctor: Ask the doctor whether the patient should be taking calcium and vitamin D together to help prevent broken bones, or if one alone would work just as well.
What's New
PubMed · May 4, 2026
Researchers carefully reviewed the tools doctors use to measure how much osteoporosis — a condition that weakens bones and raises the risk of fractures — affects a person's overall wellbeing and daily life. They found that none of the existing measurement tools performed strongly enough across all the important quality checks, which means it's currently hard to know if we're accurately capturing how people with osteoporosis truly feel. Someday, having a reliable, well-tested tool like this could help doctors better understand whether treatments are actually improving patients' lives, not just their bone strength. This is early research and hasn't yet changed treatment guidelines.
For informational purposes only. Not medical advice. Always consult a physician before making any health decisions.